Q4 2016

Latest Quarterly Results
Ended June 30, 2016

$806,578

Research and development YTD

$2,205,144

Net cash used in operations YTD

FAQ

  • What is Propanc Health Group Corporation's stock symbol?
  • Our stock is traded on the OTCQB under the symbol PPCH.

  • When was Propanc Health Group Corporation incorporated?
  • 2007

  • When did Propanc Health Group Corporation become a public company?
  • Propanc officially became a public company on December 16th, 2011.

  • Where is Propanc Health Group Corporation located?
  • 302/6 Butler Street
    Camberwell, VIC 3124
    Australia

  • When is Propanc Health Group Corporation's fiscal year end?
  • June 30th

  • Who is Propanc Health Group Corporation's transfer agent?
  • Corporate Stock Transfer Inc.
    3200 Cherry Creek South Drive
    Suite 430
    Denver, CO 80209
    T: 303-282-4800
    dbell@corporatestock.com
    www.corporatestock.com

  • Who is Propanc Health Group Corporation's independent auditor?
  • Salberg & Co
    2295 N.W. Corporate Blvd.
    Suite 240
    Boca Raton, FL 33431
    T: 561-995-8270 ext. 310
    scottsalberg@salbergco.com
    www.salbergco.com

  • Who is Propanc Health Group Corporation's outside legal counsel?
  • Harter Secrest & Emery LLP
    1600 Bausch & Lomb Place
    Rochester, NY 14604
    T: 585-232-6500

  • Whom can I contact for general information about Propanc Health Group Corporation?
  • KCSA Strategic Communications
    Philip Carlson
    880 Third Ave
    6th Floor
    New York, NY 10022
    T: 212-896-1233
    pcarlson@kcsa.com

Sign up for email alerts

Be the first to receive breaking news

Sign up today